TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised Control Trial of a Standardised and User-friendly Real-time PCR Assay for the Diagnosis of TB Using Tracheal Aspirates Obtained From Patients in the ICU
Brief Summary: Aim:

To evaluate the diagnostic utility and impact on patient outcomes of an automated PCR (Gene Xpert® MTB/RIF), in a group of patients with suspected pulmonary TB who are mechanically ventilated in ICU, using tracheal aspirates.

Hypothesis:

Gene Xpert is an accurate tool for the diagnosis of TB in the Intensive Care Unit and will impact on rates of treatment initiation and hospital stay.


Options:
A: Intervention Type: OTHER; Name: No Intervention; Assigned to Arm(s): N/A
B: Arm Label: PLHIV Centralised Xpert Ultra; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: PLHIV Point of Care Xpert Ultra; Type: ACTIVE_COMPARATOR; Interventions: Diagnostic Test: PLHIV Point of Care Xpert Ultra | Arm Label: PLHIV Centralised Xpert VL; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: PLHIV Point of Care Xpert VL; Type: ACTIVE_COMPARATOR; Interventions: Diagnostic Test: PLHIV Point of Care Xpert VL | Intervention Type: DIAGNOSTIC_TEST; Name: PLHIV Point of Care Xpert Ultra; Assigned to Arm(s): PLHIV Point of Care Xpert Ultra | Intervention Type: DIAGNOSTIC_TEST; Name: PLHIV Point of Care Xpert VL; Assigned to Arm(s): PLHIV Point of Care Xpert VL
C: Arm Label: GeneXpert; Type: ACTIVE_COMPARATOR; Interventions: Other: GeneXpert, Other: LED Microscopy | Arm Label: LED Microscopy; Type: ACTIVE_COMPARATOR; Interventions: Other: LED Microscopy | Intervention Type: OTHER; Name: GeneXpert; Assigned to Arm(s): GeneXpert | Intervention Type: OTHER; Name: LED Microscopy; Assigned to Arm(s): GeneXpert, LED Microscopy
D: Arm Label: Smear; Type: ACTIVE_COMPARATOR; Interventions: Other: Smear | Arm Label: GeneXpert; Type: EXPERIMENTAL; Interventions: Other: Xpert | Intervention Type: OTHER; Name: Xpert; Assigned to Arm(s): GeneXpert | Intervention Type: OTHER; Name: Smear; Assigned to Arm(s): Smear

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised Control Trial of a Standardised and User-friendly Real-time PCR Assay for the Diagnosis of TB Using Tracheal Aspirates Obtained From Patients in the ICU
Brief Summary: Aim:

To evaluate the diagnostic utility and impact on patient outcomes of an automated PCR (Gene Xpert® MTB/RIF), in a group of patients with suspected pulmonary TB who are mechanically ventilated in ICU, using tracheal aspirates.

Hypothesis:

Gene Xpert is an accurate tool for the diagnosis of TB in the Intensive Care Unit and will impact on rates of treatment initiation and hospital stay.


Options:
A: Arm Label: Antiretroviral therapy, tuberculosis; Type: N/A; Interventions: N/A
B: Intervention Type: DEVICE; Name: Alere "Determine" lateral-flow urine lipoarabinomannan assay; Assigned to Arm(s): N/A | Intervention Type: DEVICE; Name: Alere "Clearview" ELISA urine LAM assay; Assigned to Arm(s): N/A | Intervention Type: DEVICE; Name: Cepheid Xpert MTB/Rif assay; Assigned to Arm(s): N/A
C: Arm Label: Case detection group; Type: N/A; Interventions: Device: Investigational Xpert DST test | Arm Label: Drug resistance risk group; Type: N/A; Interventions: Device: Investigational Xpert DST test | Intervention Type: DEVICE; Name: Investigational Xpert DST test; Assigned to Arm(s): Case detection group, Drug resistance risk group
D: Arm Label: Smear; Type: ACTIVE_COMPARATOR; Interventions: Other: Smear | Arm Label: GeneXpert; Type: EXPERIMENTAL; Interventions: Other: Xpert | Intervention Type: OTHER; Name: Xpert; Assigned to Arm(s): GeneXpert | Intervention Type: OTHER; Name: Smear; Assigned to Arm(s): Smear

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised Control Trial of a Standardised and User-friendly Real-time PCR Assay for the Diagnosis of TB Using Tracheal Aspirates Obtained From Patients in the ICU
Brief Summary: Aim:

To evaluate the diagnostic utility and impact on patient outcomes of an automated PCR (Gene Xpert® MTB/RIF), in a group of patients with suspected pulmonary TB who are mechanically ventilated in ICU, using tracheal aspirates.

Hypothesis:

Gene Xpert is an accurate tool for the diagnosis of TB in the Intensive Care Unit and will impact on rates of treatment initiation and hospital stay.


Options:
A: Arm Label: LAM plus standard care; Type: EXPERIMENTAL; Interventions: Device: Urine LAM strip test | Arm Label: Standard care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Urine LAM strip test; Assigned to Arm(s): LAM plus standard care
B: Arm Label: GeneXpert; Type: ACTIVE_COMPARATOR; Interventions: Other: GeneXpert, Other: LED Microscopy | Arm Label: LED Microscopy; Type: ACTIVE_COMPARATOR; Interventions: Other: LED Microscopy | Intervention Type: OTHER; Name: GeneXpert; Assigned to Arm(s): GeneXpert | Intervention Type: OTHER; Name: LED Microscopy; Assigned to Arm(s): GeneXpert, LED Microscopy
C: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Interventional; Type: EXPERIMENTAL; Interventions: Diagnostic Test: Xpert MTB/RIF Ultra (Ultra) | Intervention Type: DIAGNOSTIC_TEST; Name: Xpert MTB/RIF Ultra (Ultra); Assigned to Arm(s): Interventional
D: Arm Label: Smear; Type: ACTIVE_COMPARATOR; Interventions: Other: Smear | Arm Label: GeneXpert; Type: EXPERIMENTAL; Interventions: Other: Xpert | Intervention Type: OTHER; Name: Xpert; Assigned to Arm(s): GeneXpert | Intervention Type: OTHER; Name: Smear; Assigned to Arm(s): Smear

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Weight-loss Diet Strategies and Exercise on Dynamics of Body Fat Depots and Metabolic Rate
Brief Summary: The investigators hypothesize that differential dynamics in fat depots in response to two opposing dietary strategies mediate the beneficial metabolic effects during weight loss and regain phases.


Options:
A: Arm Label: low fat diet; Type: EXPERIMENTAL; Interventions: Other: Weight-loss diet strategy (+) exercise (PA), Other: weight loss (-) exercise (PA) | Arm Label: low carb diet; Type: EXPERIMENTAL; Interventions: Other: Weight-loss diet strategy (+) exercise (PA), Other: weight loss (-) exercise (PA) | Intervention Type: OTHER; Name: Weight-loss diet strategy (+) exercise (PA); Assigned to Arm(s): low carb diet, low fat diet | Intervention Type: OTHER; Name: weight loss (-) exercise (PA); Assigned to Arm(s): low carb diet, low fat diet
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: low carbohydrate diet | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: low fat diet | Intervention Type: BEHAVIORAL; Name: low carbohydrate diet; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: low fat diet; Assigned to Arm(s): 2
C: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Behavioral: Choice | Arm Label: Arm 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Control | Intervention Type: BEHAVIORAL; Name: Choice; Assigned to Arm(s): Arm 1 | Intervention Type: BEHAVIORAL; Name: Control; Assigned to Arm(s): Arm 2
D: Arm Label: Low Carb; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Low- Carbohydrate -Atkins Diet | Arm Label: Low Calorie; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Low Calorie Diet | Intervention Type: BEHAVIORAL; Name: Low- Carbohydrate -Atkins Diet; Assigned to Arm(s): Low Carb | Intervention Type: BEHAVIORAL; Name: Low Calorie Diet; Assigned to Arm(s): Low Calorie

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Kidney Awareness Registry and Education Study
Brief Summary: The purpose of this study is to evaluate the feasibility and acceptability of two different interventions aimed at improving health outcomes among patients with chronic kidney disease (CKD), who are at high risk of CKD progression. Specifically, this study will examine how best to implement a provider-level intervention (access to a CKD-registry) and a patient-oriented intervention (automated telephone self-management (ATSM) + health coach) on patient health outcomes, with a 2x2 factorial design.


Options:
A: Arm Label: ATSM + Health Coach and CKD Registry; Type: EXPERIMENTAL; Interventions: Behavioral: CKD Registry, Behavioral: ATSM + Health Coach | Arm Label: CKD Registry; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: CKD Registry | Arm Label: ATSM + Health Coach; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: ATSM + Health Coach | Arm Label: Usual Care (no interventions); Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Usual care | Intervention Type: BEHAVIORAL; Name: CKD Registry; Assigned to Arm(s): ATSM + Health Coach and CKD Registry, CKD Registry | Intervention Type: BEHAVIORAL; Name: ATSM + Health Coach; Assigned to Arm(s): ATSM + Health Coach, ATSM + Health Coach and CKD Registry | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): Usual Care (no interventions)
B: Arm Label: Exercise Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Physical Activity Intervention | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Wellness control | Intervention Type: BEHAVIORAL; Name: Wellness control; Assigned to Arm(s): Control | Intervention Type: BEHAVIORAL; Name: Physical Activity Intervention; Assigned to Arm(s): Exercise Intervention
C: Arm Label: A Helping Hand (AHH); Type: EXPERIMENTAL; Interventions: Behavioral: Self-care management | Arm Label: Usual Care (UC); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Self-care management; Assigned to Arm(s): A Helping Hand (AHH)
D: Arm Label: Health Promotion; Type: EXPERIMENTAL; Interventions: Behavioral: Happy Older Latinos are Active | Arm Label: Psychoeducation; Type: ACTIVE_COMPARATOR; Interventions: Other: Fotonovela | Intervention Type: BEHAVIORAL; Name: Happy Older Latinos are Active; Assigned to Arm(s): Health Promotion | Intervention Type: OTHER; Name: Fotonovela; Assigned to Arm(s): Psychoeducation

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Kidney Awareness Registry and Education Study
Brief Summary: The purpose of this study is to evaluate the feasibility and acceptability of two different interventions aimed at improving health outcomes among patients with chronic kidney disease (CKD), who are at high risk of CKD progression. Specifically, this study will examine how best to implement a provider-level intervention (access to a CKD-registry) and a patient-oriented intervention (automated telephone self-management (ATSM) + health coach) on patient health outcomes, with a 2x2 factorial design.


Options:
A: Arm Label: usual care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Health Communication Application; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Interactive Health Communication Application | Intervention Type: BEHAVIORAL; Name: Interactive Health Communication Application; Assigned to Arm(s): Health Communication Application
B: Arm Label: Computerised CBT with therapist support; Type: EXPERIMENTAL; Interventions: Behavioral: Computerised Cognitive Behavioural Therapy, Behavioral: Telephone support | Arm Label: Computerised CBT without therapist support; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Computerised Cognitive Behavioural Therapy | Intervention Type: BEHAVIORAL; Name: Computerised Cognitive Behavioural Therapy; Assigned to Arm(s): Computerised CBT with therapist support, Computerised CBT without therapist support | Intervention Type: BEHAVIORAL; Name: Telephone support; Assigned to Arm(s): Computerised CBT with therapist support
C: Arm Label: Pharmacist intervention; Type: EXPERIMENTAL; Interventions: Other: Pharmacist based QI program | Arm Label: Control - usual care; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual Care | Intervention Type: OTHER; Name: Pharmacist based QI program; Assigned to Arm(s): Pharmacist intervention | Intervention Type: OTHER; Name: Usual Care; Assigned to Arm(s): Control - usual care
D: Arm Label: ATSM + Health Coach and CKD Registry; Type: EXPERIMENTAL; Interventions: Behavioral: CKD Registry, Behavioral: ATSM + Health Coach | Arm Label: CKD Registry; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: CKD Registry | Arm Label: ATSM + Health Coach; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: ATSM + Health Coach | Arm Label: Usual Care (no interventions); Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Usual care | Intervention Type: BEHAVIORAL; Name: CKD Registry; Assigned to Arm(s): ATSM + Health Coach and CKD Registry, CKD Registry | Intervention Type: BEHAVIORAL; Name: ATSM + Health Coach; Assigned to Arm(s): ATSM + Health Coach, ATSM + Health Coach and CKD Registry | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): Usual Care (no interventions)

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Kidney Awareness Registry and Education Study
Brief Summary: The purpose of this study is to evaluate the feasibility and acceptability of two different interventions aimed at improving health outcomes among patients with chronic kidney disease (CKD), who are at high risk of CKD progression. Specifically, this study will examine how best to implement a provider-level intervention (access to a CKD-registry) and a patient-oriented intervention (automated telephone self-management (ATSM) + health coach) on patient health outcomes, with a 2x2 factorial design.


Options:
A: Arm Label: Group Based; Type: EXPERIMENTAL; Interventions: Behavioral: Group-Based (GB) Intervention | Arm Label: Home-Based; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Home-Based (HB) Intervention | Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Group-Based (GB) Intervention; Assigned to Arm(s): Group Based | Intervention Type: BEHAVIORAL; Name: Home-Based (HB) Intervention; Assigned to Arm(s): Home-Based
B: Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: mHealth; Type: EXPERIMENTAL; Interventions: Behavioral: mHealth | Intervention Type: BEHAVIORAL; Name: mHealth; Assigned to Arm(s): mHealth
C: Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral Contract | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Behavioral Contract; Assigned to Arm(s): Intervention Group
D: Arm Label: ATSM + Health Coach and CKD Registry; Type: EXPERIMENTAL; Interventions: Behavioral: CKD Registry, Behavioral: ATSM + Health Coach | Arm Label: CKD Registry; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: CKD Registry | Arm Label: ATSM + Health Coach; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: ATSM + Health Coach | Arm Label: Usual Care (no interventions); Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Usual care | Intervention Type: BEHAVIORAL; Name: CKD Registry; Assigned to Arm(s): ATSM + Health Coach and CKD Registry, CKD Registry | Intervention Type: BEHAVIORAL; Name: ATSM + Health Coach; Assigned to Arm(s): ATSM + Health Coach, ATSM + Health Coach and CKD Registry | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): Usual Care (no interventions)

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Role Of Lactobacillus Reuteri in Preventing Necrotizing Enterocolitis in Very Low Birth Weight Infants
Brief Summary: Probiotics are favorable microorganisms that regulate the flora of the gastrointestinal system and stimulate the immune system. Necrotizing enterocolitis incidence is 10-25% in newborn infants whose birth weights are \< 1500 g. Although bifidobacterium and other lactobacilli spp. have been used to reduce the incidence of necrotizing enterocolitis in clinical trials, Lactobacillus reuteri has not been used in the prevention of necrotizing enterocolitis in very low birth weight infants yet. The objective of this study is to evaluate the efficacy of orally administered Lactobacillus reuteri in reducing the incidence and severity of necrotizing enterocolitis in very low birth weight infants.


Options:
A: Arm Label: Maltodextrin; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Probiotic supplementation | Arm Label: Probiotic B lactis/B longum; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Probiotic supplementation | Arm Label: Probiotic B longum; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Probiotic supplementation | Arm Label: Probiotic B lactis; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Probiotic supplementation | Intervention Type: DIETARY_SUPPLEMENT; Name: Probiotic supplementation; Assigned to Arm(s): Maltodextrin, Probiotic B lactis, Probiotic B lactis/B longum, Probiotic B longum
B: Arm Label: Lactobacillus reuteri; Type: EXPERIMENTAL; Interventions: Drug: Lactobacillus reuteri | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Lactobacillus reuteri; Assigned to Arm(s): Lactobacillus reuteri | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Control
C: Intervention Type: DIETARY_SUPPLEMENT; Name: Probiotics supplementation until weight reaches 1800g (Bifidobacterium Longum and Lactobacillus GG ); Assigned to Arm(s): N/A
D: Arm Label: 1; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Lactobacillus reuteri | Intervention Type: DIETARY_SUPPLEMENT; Name: Lactobacillus reuteri; Assigned to Arm(s): 2 | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): 1

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Role Of Lactobacillus Reuteri in Preventing Necrotizing Enterocolitis in Very Low Birth Weight Infants
Brief Summary: Probiotics are favorable microorganisms that regulate the flora of the gastrointestinal system and stimulate the immune system. Necrotizing enterocolitis incidence is 10-25% in newborn infants whose birth weights are \< 1500 g. Although bifidobacterium and other lactobacilli spp. have been used to reduce the incidence of necrotizing enterocolitis in clinical trials, Lactobacillus reuteri has not been used in the prevention of necrotizing enterocolitis in very low birth weight infants yet. The objective of this study is to evaluate the efficacy of orally administered Lactobacillus reuteri in reducing the incidence and severity of necrotizing enterocolitis in very low birth weight infants.


Options:
A: Arm Label: 2; Type: EXPERIMENTAL; Interventions: Dietary Supplement: infloran | Intervention Type: DIETARY_SUPPLEMENT; Name: infloran; Assigned to Arm(s): 2 | Intervention Type: DIETARY_SUPPLEMENT; Name: infloran; Assigned to Arm(s): 2
B: Arm Label: Lactobacillus reuteri; Type: EXPERIMENTAL; Interventions: Drug: Lactobacillus reuteri | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Lactobacillus reuteri; Assigned to Arm(s): Lactobacillus reuteri | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Control
C: Arm Label: 1; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Lactobacillus reuteri | Intervention Type: DIETARY_SUPPLEMENT; Name: Lactobacillus reuteri; Assigned to Arm(s): 2 | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): 1
D: Arm Label: Probiotics; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Probiotics | Arm Label: Probiotics + Dietary counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary counselling and probiotics | Arm Label: Dietary counseling + placebo; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary counselling and placebo | Arm Label: Prebiotics; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Prebiotics | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo capsules | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Dietary counselling and placebo; Assigned to Arm(s): Dietary counseling + placebo | Intervention Type: BEHAVIORAL; Name: Dietary counselling and probiotics; Assigned to Arm(s): Probiotics + Dietary counseling | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo capsules; Assigned to Arm(s): Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Probiotics; Assigned to Arm(s): Probiotics | Intervention Type: DIETARY_SUPPLEMENT; Name: Prebiotics; Assigned to Arm(s): Prebiotics

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized, Double-Blind, Placebo-Controlled Trial Of Azithromycin In Campylobacter Concisus Positive Patients With Diarrhea
Brief Summary: A randomized, double-blind, placebo-controlled clinical trial of azithromycin in Campylobacter concisus culture positive patients with diarrhea. The clinical characteristics of emerging Campylobacter concisus in adults is vomiting and persistent diarrhea. Whether patients may benefit from antibiotic treatment is unknown. The purpose of this trial is to investigate whether antibiotic treatment with azithromycin of Campylobacter concisus induced diarrhea can better the symptoms and shorten the duration of illness.


Options:
A: Arm Label: Clarithromycin; Type: EXPERIMENTAL; Interventions: Drug: Clarithromycin, Drug: VCD induction therapy | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Drug: VCD induction therapy | Intervention Type: DRUG; Name: Clarithromycin; Assigned to Arm(s): Clarithromycin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: VCD induction therapy; Assigned to Arm(s): Clarithromycin, Placebo
B: Arm Label: Moxifloxacin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Moxifloxacin | Arm Label: Azithromycin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Azithromycin | Arm Label: Doxycycline; Type: ACTIVE_COMPARATOR; Interventions: Drug: Doxycycline | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Moxifloxacin; Assigned to Arm(s): Moxifloxacin | Intervention Type: DRUG; Name: Azithromycin; Assigned to Arm(s): Azithromycin | Intervention Type: DRUG; Name: Doxycycline; Assigned to Arm(s): Doxycycline | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Biannual mass oral azithromycin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Azithromycin | Arm Label: Biannual mass oral placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Azithromycin; Assigned to Arm(s): Biannual mass oral azithromycin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Biannual mass oral placebo
D: Arm Label: azithromycin; Type: ACTIVE_COMPARATOR; Interventions: Drug: azithromycin | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: azithromycin; Assigned to Arm(s): azithromycin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): placebo

Answer: D